In inflammatory bowel disease, particularly Crohn’s disease and ulcerative colitis, SOCS3 modulates inflammation at various stages of the disease, with increased SOCS3 expression in macrophages and T cells linked to disease severity and inflammation control (39–41). This evidence concerns the gene SOCS3 and inflammatory bowel disease.